2024

1. A mammalian-specific Alex3/Gαq protein complex regulates mitochondrial trafficking, dendritic complexity, and neuronal survival

   Science Signaling, Vol. 17, Núm. 822

2. A systematic review of progranulin concentrations in biofluids in over 7,000 people—assessing the pathogenicity of GRN mutations and other influencing factors

   Alzheimer's Research and Therapy, Vol. 16, Núm. 1

3. An emerging epidemic of allergic contact dermatitis due to phytonadione epoxide (oxidised vitamin K1)

   Contact Dermatitis, Vol. 91, Núm. 5, pp. 379-386

4. AntimiR treatment corrects myotonic dystrophy primary cell defects across several CTG repeat expansions with a dual mechanism of action

   Science advances, Vol. 10, Núm. 41, pp. eadn6525

5. Anxious and depressive symptoms and health-related quality of life in a cohort of people who recently attempted suicide: A network analysis

   Journal of Affective Disorders, Vol. 355, pp. 210-219

6. Association between type 2 diabetes and depressive symptoms after a 1-year follow-up in an older adult Mediterranean population

   Journal of Endocrinological Investigation, Vol. 47, Núm. 6, pp. 1405-1418

7. At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods

   Scientific Reports, Vol. 14, Núm. 1

8. Bacille Calmette-Guérin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trial

   eClinicalMedicine, Vol. 72

9. Behavioral therapy in migraine: Expanding the therapeutic arsenal

   European Journal of Neurology

10. C-reactive protein-complement factor H axis as a biomarker of activity in early and intermediate age-related macular degeneration

    Frontiers in Immunology, Vol. 15

11. Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities

    Pediatric Blood and Cancer, Vol. 71, Núm. 8

12. Cardiac resynchronization therapy with triple fusion using the SyncAV dynamic algorithm compared to conventionally optimized biventricular pacing: Results from the multicentric, randomized, double-blinded CRUSTY trial

    Heart Rhythm

13. Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry

    Therapeutic Advances in Gastroenterology, Vol. 17

14. Clinical predictors and psychosocial risk factors of suicide attempt severity

    Spanish Journal of Psychiatry and Mental Health

15. Consensus document on the implications of standardization of BCG supply in the management of patients with non-muscle-invasive bladder cancer

    Actas Urologicas Espanolas

16. Contilisant+Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases

    Journal of Medicinal Chemistry, Vol. 67, Núm. 18, pp. 16533-16555

17. Correction in article by Juzga-Corrales et al. “Characteristics and outcomes of the Spanish registry for pediatric patients with bicuspid aortic valve (REVAB)”, Rev Esp Cardiol. 2023;76:961-969 (Revista Española de Cardiología (English Edition) (2024) 77(4) (358–359), (S1885585724000331), (10.1016/j.rec.2023.12.011))

    Revista Espanola de Cardiologia

18. Correction to: Temporal and sex-dependent gene expression patterns in a renal ischemia–reperfusion injury and recovery pig model (Scientific Reports, (2022), 12, 1, (6926), 10.1038/s41598-022-10352-3)

    Scientific Reports

19. Corrigendum to “Prolactin and morning cortisol concentrations in antipsychotic naïve first episode psychosis: A systematic review and meta-analysis” [Psychoneuroendocrinology 150 (2023) 106049] (Psychoneuroendocrinology (2023) 150, (S0306453023000276), (10.1016/j.psyneuen.2023.106049))

    Psychoneuroendocrinology

20. Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg versus other long-acting reversible contraceptives for contraception in Spain

    European Journal of Contraception and Reproductive Health Care, Vol. 29, Núm. 5, pp. 224-232